(Q33346032)

26 July 2017

1 reference

title

Management of patients with severe sepsis, treated by drotrecogin alfa (activated). (English)

1 reference

26 July 2017

0 references

1 reference

Pierre-François Laterre

series ordinal

1

1 reference

26 July 2017

Darell Heiselman

series ordinal

2

1 reference

26 July 2017

language of work or name

English

0 references

publication date

1 December 2002

1 reference

The American Journal of Surgery

26 July 2017

published in

1 reference

26 July 2017

volume

184

1 reference

26 July 2017

issue

6A Suppl

1 reference

26 July 2017

page(s)

S39-46

1 reference

Derangements of coagulation and fibrinolysis in critically ill patients with sepsis and septic shock

26 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2901135-2

Vascular bed-specific hemostasis: role of endothelium in sepsis pathogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2901135-2

Efficacy and safety of recombinant human activated protein C for severe sepsis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2901135-2

The inhibition of blood coagulation by activated protein C through the selective inactivation of activated factor V

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2901135-2

Protein C prevents the coagulopathic and lethal effects of Escherichia coli infusion in the baboon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2901135-2

Gene expression profile of antithrombotic protein c defines new mechanisms modulating inflammation and apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2901135-2

Generation of fibrinolytic activity by infusion of activated protein C into dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2901135-2

Preparation and properties of bovine factor VIII (antihemophilic factor).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2901135-2

Prognostic value of protein C concentrations in neutropenic patients at high risk of severe septic complications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2901135-2

Dysfunction of Endothelial Protein C Activation in Severe Meningococcal Sepsis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2901135-2

Disseminated intravascular coagulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2901135-2

Treatment dilemma in childhood idiopathic thrombocytopenic purpura

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2901135-2

A comparative double-blind randomized trial of activated protein C and unfractionated heparin in the treatment of disseminated intravascular coagulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2901135-2

10.1016/S0002-9610(02)01135-2

7 January 2021

Identifiers

DOI

1 reference

26 July 2017

1 reference